Trends in HIV seroprevalence among tuberculosis patients in 4 districts, 2005–6 survey and 2006–7 surveys.

<p>Trends in HIV seroprevalence among tuberculosis patients in 4 districts, 2005–6 survey and 2006–7 surveys.</p

HIV seroprevalence among tuberculosis patients in 15 districts in India, 2006–2007.

a<p>Districts stratified by mean HIV seroprevalence in antenatal clinic (ANC) surveillance sites, 2003–2005. Low <0.5%, Medium = 0.51–1.0%, High >1.0%.</p

Survey enrollment and inclusion, with reasons for non-eligibility and non-enrollment into survey.

<p>Survey enrollment and inclusion, with reasons for non-eligibility and non-enrollment into survey.</p

Districts selected for the survey.

<p>District selection stratified by mean HIV seroprevalence in antenatal clinic (ANC) surveillance sites, 2003–2005. Districts shaded blue had mean 2003–2005 ANC HIV seroprevalence 0–0.5%, yellow districts had ANC HIV seroprevalence 0.51–1.0%, and red districts had ANC HIV seroprevalence >1.0%. The districts of Davangere, Guntur, Nasik, and Tiruvanamalai were selected in the previous years' survey, and were purposively selected again for trend analysis.</p

Bivariate analysis of risk factors for mortality during TB treatment among HIV-infected TB patients, Andhra Pradesh 2007 (N = 734).

<p>Bivariate analysis of risk factors for mortality during TB treatment among HIV-infected TB patients, Andhra Pradesh 2007 (N = 734).</p

Tuberculosis treatment outcomes among HIV-infected TB patients, Andhra Pradesh 2007 (N = 734).

<p>Abbreviations: NSP–new pulmonary tuberculosis with sputum smears positive for acid-fast bacilli; NSN–new pulmonary tuberculosis with sputum smears negative for acid-fast bacilli; NEP–New extrapulmonary tuberculosis.</p

Multivariate analysis of risk factors for mortality during TB treatment among HIV-infected TB patients, Andhra Pradesh 2007 (n = 713).

<p>Multivariate analysis of risk factors for mortality during TB treatment among HIV-infected TB patients, Andhra Pradesh 2007 (n = 713).</p

Kaplan-Meier survival curve for HIV-infected TB patients, by exposure to antiretroviral treatment.

<p>ART = antiretroviral treatment, TB = tuberculosis.</p